Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07414511 · ClinicalTrials.gov registry record

Hemophilia A Research Program

A clinical trial of Pregnancy and Hemophilia A, sponsored by University of Washington.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT07414511 is a study of Pregnancy and Hemophilia A that is actively recruiting participants, run by University of Washington. The registered enrollment target is 500 participants, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07414511, a study of Pregnancy and Hemophilia A, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

This study longitudinally observes the intergenerational (mother-child) continuum in hemophilia A from pregnancy through early childhood. Because the study follows mother-child pairs, the study includes both a maternal cohort and a pediatric cohort. Each cohort has a primary goal: for the mother with a severe hemophilia genotype, the overarching primary goal is to understand the risks for pregnancy-associated bleeding and postpartum hemorrhage (PPH); for the child, the overarching primary goal is to understand the risks, timing, and circumstances of development of anti-FVIII antibodies. From a longitudinal perspective, risks for both bleeding in the mother and anti-FVIII antibody development in the child are expected to be influenced over time by genetic and environmental factors that begin early in (or before) pregnancy. Enrollment of blood relatives is offered to improve power to better understand inherited contributions to bleeding and inhibitor development in the mother-baby pairs.

Conditions Studied

Pregnancy Hemophilia A Pregnancy Complications Bleeding Disorder Factor VIII (FVIII) Maternal Blood Loss Hemophilia A, Severe FVIII Deficiency Carrier of Hemophilia A Inhibitors

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-07-31
Est. Completion 2029-08

Sponsor

University of Washington

1,048 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07414511

The ClinicalTrials.gov registry entry for NCT07414511 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (43% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.

NCT07414511 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT07414511 about?

NCT07414511 is a clinical study titled "Hemophilia A Research Program". This study longitudinally observes the intergenerational (mother-child) continuum in hemophilia A from pregnancy through early childhood. Because the study follows mother-child pairs, the study includes both a maternal cohort and a pediatric cohort. Each cohort has a primary goal: for the mother wit...

What is the current status of trial NCT07414511?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-07-31. Estimated completion is 2029-08.

What conditions does trial NCT07414511 study?

This clinical trial studies the following conditions: Pregnancy, Hemophilia A, Pregnancy Complications, Bleeding Disorder, Factor VIII (FVIII).

Who is sponsoring clinical trial NCT07414511?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07414511 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pregnancy

All registered trials for this condition

Hemophilia A

All registered trials for this condition

Washington

All trials with a study site in Washington

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.